Artificial Insemination Market Report

Artificial Insemination Market Analysis By Type (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination), By End-use, By Source Type, And Segment Forecasts, 2018 - 2025

  • Published Date: May, 2018
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-176-4
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 80

Industry Insights

The global Artificial Insemination market size was valued at around USD 1.4 billion in 2017 and is expected to grow at a CAGR of 8% over the forecast period. Over the past few years, the rate of infertility has been increasing across the globe. According to WHO, around 10% of women are directly or indirectly affected by infertility. In addition, National Institutes of Health reported that infertility affects around 12% of couples of reproductive age.

U.S. artificial insemination market

The WHO monitors the prevalence of infertility across the globe in-line with ‘WHO Reproductive Health Indicators, Guidelines for their generation, interpretation and analysis for global monitoring’. The exact estimation of infertility is challenging due to the complex nature of factors of female and male infertility.

At present, 46% of the global population lives in countries reported to have low levels of fertility. Another 46% population lives in countries with intermediate levels of fertility and the remaining 8% lives in countries reported to have high fertility. According to United Nations, the global rate of fertility is expected to decline to 2.4 by 2030 and 2.2 by 2050.

Artificial insemination is usually the first line of treatment for infertility. Earlier, Assisted Reproductive Technologies (ARTs) were taboo as they were considered immoral, unnatural, or unethical. Families with children conceived by ARTs experienced judgments from their communities, relatives, and friends.

In some countries, including the U.S. and the UK, lesbian couples are provided insurance coverage for artificial insemination procedures. According to guidelines of National Institute for Health and Clinical Excellence (NICE), same-sex couples should be eligible for fertility treatments. NHS expects lesbian couples to undergo six cycles of self-funded artificial insemination to be able to avail NHS-funded fertility treatments.

Type Insights

Intrauterine Insemination (IUI) held majority of the market share in 2017 and is likely to be one of the fastest-growing segments over the forecast period. It is considered the most commonly used method for conception. It involves the deposition of a sperm sample in the uterus with the help of a catheter. It is usually a noninvasive method that can be performed with or without drugs. Chances of conception are higher with this method as compared to other types of insemination because the sperm sample is placed closest to the eggs.

Intravaginal insemination is likely to be the second fastest-growing segment during the forecast period. This procedure can be performed at home as well as in fertility clinics. As it involves placing the sperm sample in the vagina, chances of pregnancy are lower as compared to intrauterine insemination. However, as it can be performed at home, single women and lesbians usually prefer it as a first-line treatment.

In addition, some of the market players offer home-use kits that consist of insemination devices, ovulation kits, and pregnancy detection kits. Frozen sperm samples can be availed from registered sperm banks.

End-use Insights

Fertility clinics held majority of the market share in 2017. The number of medical centers providing treatment for infertility has been increasing over the past few years due to increase in the prevalence of infertility across the world. Invasive methods, such as intrauterine insemination and intratubal insemination are performed in fertility clinics. Moreover, fertility clinics also provide sperm washing, a process to prepare a sperm sample for insemination by eliminating impurities from the semen, which helps increase the chances of conception.

Insemination procedures at clinics involve consultation, in which the ovulation cycle is detected before initiating the procedures. In addition, doctors can prescribe fertility medication to increase chances of conception.

Source Type Insights

Artificial insemination by husband or AIH dominated the source type segment in terms of market share. It is also expected to witness the fastest growth rate over the forecast period. Semen donation by the husband or partner is preferred in female infertility issues including mild endometriosis, cervical disorders, etc. On the other hand, donor insemination is opted as a last resort, by the couples with non-viable sperm. Single women or same-sex couples also can choose donor insemination. The market for donor sperm in AI or AID is also expected witness lucrative growth rate owing to single women and lesbian couples in countries such as UK, Brazil, and Mexico, which allows to opt for assisted reproductive technologies by using donor sperm samples.

Regional Insights

North America held the more than 20% market share in 2017 as the fertility rate in the region has been decreasing over the years. Delay in pregnancy and lifestyle changes are among factors contributing to this decline. According to Population Reference Bureau, the average fertility rate in this region is around 2.0 per woman as of 2009. In 2016, the fertility rate in the U.S. was at a record low. There were only 62.5 births per 1000 women, according to National Center for Health Statistics. The U.S. population is below replacement level as per the current fertility rate. In addition, around 17% people in Canada are struggling to conceive.

Artificial insemination market

Asia Pacific is expected to be the fastest-growing market segment in the coming years due to increase in the rate of infertility in this region and rise in awareness about available treatment options. Population growth in Japan has declined sharply since 1970s. According to 2010 census, around 56% households were nuclear families and 32% were single-person households. Moreover, in China, 40 million people were estimated to be infertile in 2012.

Artificial Insemination Market Share Insights

Some of the key market players are Irvine Scientific; Rinovum Women’s Health, LLC; Pride Angel; Hi-Tech Solutions; Conceivex, Inc.; TenderNeeds Fertility, among others. These companies offer home insemination kits, insemination tools, and solutions for sperm washing. Some of the market players are acquiring companies to strengthen their presence in other regional markets. For example, Irvine Scientific acquired BioCare Europe S.r.l, a distributor of media, devices, and equipment, that are required for assisted reproductive techniques.

Report Scope

Attribute

Details

Base year for estimation

2017

Actual estimates/Historic data

2014 - 2017

Forecast period

2018 - 2025

Market representation

Revenue in USD Million & CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, UK, Germany, Japan, China, India, Brazil, Mexico, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors & trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments covered in the report

This report forecasts revenue growth and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global artificial insemination market report based on type, end use, and region:

  • Type Outlook (Revenue, USD Million; 2014 - 2025)

    • Intrauterine Insemination

    • Intracervical Insemination

    • Intravaginal Insemination

    • Intratubal Insemination

  • End-use Outlook (Revenue, USD Million; 2014 - 2025)

    • Fertility Clinics and Others

    • Home

  • Source Type Outlook (Revenue, USD Million; 2014 - 2025)

    • AIH - Husband

    • AID - Donor

  • Regional Outlook (Revenue, USD Million; 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
Compass Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified